Search research articles
Contact Us
Filters
Showing results (91-100 of 224) with videos related to
Page
of 23
Sort By:
Blood
|
February 1, 2007
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome
Pierre Fenaux, Azra Raza, Ghulam J Mufti, et al.
Journal of Leukocyte Biology
|
November 13, 2003
Cyclin D2 controls B cell progenitor numbers
Azim Mohamedali, Inês Soeiro, Nicholas C Lea, et al.
Biochemical and Biophysical Research Communications
|
June 21, 2005
Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia
Barbara-Ann Guinn, Amanda F Gilkes, Eleanor Woodward, et al.
Annals of Hematology
|
February 13, 2008
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
Aristoteles Giagounidis, Pierre Fenaux, Ghulam J Mufti, et al.
Therapeutic Drug Monitoring
|
August 3, 2017
Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men
Sarah L Belsey, Robin Ireland, Kathryn Lang, et al.
Genes, Chromosomes & Cancer
|
February 24, 2015
A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells
Joseph F Collin, James W Wells, Barbara Czepulkowski, et al.
British Journal of Haematology
|
June 16, 2015
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells
Clodagh Keohane, Shahram Kordasti, Thomas Seidl, et al.
Blood
|
March 11, 2008
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
Piers E M Patten, Andrea G S Buggins, Julie Richards, et al.
British Journal of Haematology
|
July 5, 2007
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes
Zi Yi Lim, Laurence Pearce, Aloysius Y Ho, et al.
The Lancet. Haematology
|
December 22, 2015
CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis
Alexander E Smith, Austin G Kulasekararaj, Jie Jiang, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 224) with videos related to
Sort By:
Page
of 23
Blood
|
February 1, 2007
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome
Pierre Fenaux, Azra Raza, Ghulam J Mufti, et al.
Journal of Leukocyte Biology
|
November 13, 2003
Cyclin D2 controls B cell progenitor numbers
Azim Mohamedali, Inês Soeiro, Nicholas C Lea, et al.
Biochemical and Biophysical Research Communications
|
June 21, 2005
Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia
Barbara-Ann Guinn, Amanda F Gilkes, Eleanor Woodward, et al.
Annals of Hematology
|
February 13, 2008
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
Aristoteles Giagounidis, Pierre Fenaux, Ghulam J Mufti, et al.
Therapeutic Drug Monitoring
|
August 3, 2017
Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men
Sarah L Belsey, Robin Ireland, Kathryn Lang, et al.
Genes, Chromosomes & Cancer
|
February 24, 2015
A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells
Joseph F Collin, James W Wells, Barbara Czepulkowski, et al.
British Journal of Haematology
|
June 16, 2015
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells
Clodagh Keohane, Shahram Kordasti, Thomas Seidl, et al.
Blood
|
March 11, 2008
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
Piers E M Patten, Andrea G S Buggins, Julie Richards, et al.
British Journal of Haematology
|
July 5, 2007
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes
Zi Yi Lim, Laurence Pearce, Aloysius Y Ho, et al.
The Lancet. Haematology
|
December 22, 2015
CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis
Alexander E Smith, Austin G Kulasekararaj, Jie Jiang, et al.
Page
of 23